Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Astrazeneca, Atsena, GSK, H. Lundbeck, Haisco, Ibex, Inhibikase, Momentis, Nuvectis, Pfizer, Revolution, Sentante, Traferox.